Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches

Area of Science:

• Oncology
• Metabolic pathways
• Cancer biology

Background:

• Cancer cells exhibit altered metabolic pathways crucial for their growth and survival.
• Metabolic reprogramming is a hallmark of cancer, supporting tumor formation and providing therapeutic vulnerabilities.
• Historical research, including Otto Warburg's work on aerobic glycolysis, laid the foundation for understanding cancer metabolism.

Purpose of the Study:

• To explore novel therapeutic strategies targeting cancer cell metabolism.
• To investigate the efficacy of inhibiting major metabolic pathways in cancer treatment.
• To highlight the role of metabolic reprogramming in neoplastic cell treatment.

Main Methods:

• Inhibition of key metabolic pathways including glycolysis, pentose phosphate pathway (PPP), fatty acid synthesis, and mitochondrial metabolism.
• Utilizing metabolic liabilities for cancer treatment.
• Combination therapy with chemotherapies.
• Preclinical models for evaluating metabolic targeting agents.
• Application of multi-omics, single-cell, and spatial technologies for metabolic tracking.

Main Results:

• Inhibiting major metabolic pathways demonstrates efficacy in treating neoplastic cells.
• Metabolic reprogramming combined with chemotherapy is a successful approach for cancer management.
• Metabolic molecules targeting nucleic acid synthesis and other biochemical processes are under investigation.
• Advanced technologies enable accurate tracking of cancer metabolism.

Conclusions:

• Targeting cancer cell metabolism represents a promising and emerging therapeutic approach.
• Metabolic reprogramming is a viable strategy for cancer treatment and management.
• Continued research and technological advancements are crucial for refining metabolic therapies.